These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 941920)

  • 21. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug usage guidelines, Part 3: assessment of acceptance of the program.
    Patry RA; Huber SL; Rice G; Hudson HD; Godwin HN
    Hosp Formul; 1985 Apr; 20(4):464, 470-4. PubMed ID: 10270728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment and operation of an oncology satellite pharmacy.
    Eddlemon JK; Hayman JN; Breland BD
    Am J Hosp Pharm; 1984 Oct; 41(10):2045-8. PubMed ID: 6496493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidisciplinary adverse drug reaction surveillance program.
    Prosser TR; Kamysz PL
    Am J Hosp Pharm; 1990 Jun; 47(6):1334-9. PubMed ID: 2368727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
    Segal R; Pathak DS
    Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacy formularies in integrated health systems.
    Osborne JA
    J Healthc Resour Manag; 1997; 15(1):18-20. PubMed ID: 10164678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of pharmacy and therapeutics committee drug evaluation reports.
    Majercik PL; May JR; Longe RL; Johnson MH
    Am J Hosp Pharm; 1985 May; 42(5):1073-6. PubMed ID: 4003418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computer-based support system for formulary decisions.
    Senthilkumaran K; Shatz SM; Kalies RF
    Am J Hosp Pharm; 1987 Jun; 44(6):1362-6. PubMed ID: 3618613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing guidelines for biotechnology drug use: experience with antithrombin III.
    Romac DR; Poole P; Owings JT; Mahackian K; Foulke G; Tharratt RS; Albertson TE
    Formulary; 1995 Sep; 30(9):520-3, 525-7, 531. PubMed ID: 10151737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purchasing and inventory control--past, present, and future.
    Skolaut MW; McAllister JC
    Am J Hosp Pharm; 1984 Mar; 41(3):522-5. PubMed ID: 6702857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twenty years' experience with drug information centers.
    Amerson AB; Wallingford DM
    Am J Hosp Pharm; 1983 Jul; 40(7):1172-8. PubMed ID: 6881155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American Society of Hospital Pharmacists. Product selection survey.
    Am J Hosp Pharm; 1972 Jun; 29(6):506. PubMed ID: 5035970
    [No Abstract]   [Full Text] [Related]  

  • 35. Formulary management to reduce cost: P & T committee strategies.
    Roberts MJ; Summerfield MR
    Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulary-control procedures in a staff-model health maintenance organization.
    Lyon RA
    Am J Hosp Pharm; 1990 Feb; 47(2):340-2. PubMed ID: 2106782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of drug reports for the P&T Committee.
    Longe RL; Cross GW; Riley MW
    Hosp Formul; 1978 Mar; 13(3):228-9. PubMed ID: 10306915
    [No Abstract]   [Full Text] [Related]  

  • 39. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial formulary management: meeting the challenge in a health maintenance organization.
    Carlson JA
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):32S-35S. PubMed ID: 2011571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.